【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures 10
2 Pharmaceuticals & Healthcare, Global, Deal Summary 13
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, June 2013 13
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, June 2013 15
2.2.1 Tenet Healthcare to Acquire Vanguard Health Systems for US$4.3 Billion 15
2.2.2 Baxter Completes Public Offering of Notes for $3.5 Billion 16
2.2.3 Thermo Fisher Announces Underwriters’ Exercise of Over-Allotment Option for Public Offering of Shares for US$2.53 Billion 16
2.2.4 Valeant Pharma Completes Public Offering of Shares for US$2.3 Billion 17
2.2.5 KKR to Acquire PRA International from Genstar Capital 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, June 2013 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, June 2013 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, June 2013 21
3.1.1 Top M&A Deals in June 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, January 2013 – June 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, June 2013 25
3.2.1 Top Equity Offering Deals in June 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, January 2013 – June 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, June 2013 29
3.3.1 Top PE/VC Deals in June 2013 30
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, June 2013 31
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, June 2013 32
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, January 2013–June 2013 34
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, January 2013–June 2013 35
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, June 2013 36
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, June 2013 36
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, January 2013 – June 2013 38
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), June 2013 40
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, June 2013 41
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), January 2013 – June 2013 42
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, January 2013 – June 2013 44
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), January 2013 – June 2013 45
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), January 2013 – June 2013 46
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2013 48
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2013 48
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), June 2013 50
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, June 2013 51
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, June 2013 51
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, June 2013 52
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), January 2013 – June 2013 53
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), January 2013 – June 2013 55
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), January 2013 – June 2013 57
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), January 2013 – June 2013 59
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 61
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, June 2013 61
6.1.1 Oncology – Deals of the Month 63
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, June 2013 64
6.2.1 Central Nervous System – Deals of the Month 66
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, June 2013 67
6.3.1 Infectious Diseases – Deals of the Month 69
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, June 2013 70
6.4.1 Cardiovascular – Deal of the Month 71
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, June 2013 73
6.5.1 Metabolic Disorders – Deal of the Month 75
6.6 Pharmaceuticals & Healthcare, Global, Immunology Deals, June 2013 76
6.6.1 Immunology – Deal of the Month 77
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, June 2013 78
6.7.1 Gastrointestinal – Deal of the Month 79
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, June 2013 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, June 2013 83
7.2.1 Europe – Deals of the Month 84
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, June 2013 86
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, June 2013 89
7.4.1 Rest of the World – Deals of the Month 90
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 92
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, January 2013 – June 2013 92
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, January 2013 – June 2013 94
9 Further Information 96
9.1 Methodology 96
9.2 About GlobalData 97
9.3 Disclosure information 98
9.4 Disclaimer 98
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：June 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for June 2013 in Pharmaceuticals
■ 発行日：2013年7月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161513
■ 調査対象地域：グローバル
- 世界のアイスクリーム市場のニュース及びイベント動向（2014年6月）Synopsis The report provides a review of the latest news and key events in the global ice cream market during June 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global ice cream market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global ic …
- 世界のバイオガスエネルギー変換装置市場動向（2012-2016）TechNavio's analysts forecast the Global Biogas Upgrading Equipment market to grow at a CAGR of 21.96 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in benefits of biogas. The Global Biogas Upgrading Equipment market has also been witnessing the strengthening rural economy. However, the increase in barriers to the development of biogas …
- 透明導電体としての金属網(メッシュ)市場2014This report analyzes new developments in metal meshes that make them a serious contender as a TC. While all metal-based TCs used to be lumped together in one category, the TC industry now distinguishes between metal meshes, in which the metal is patterned in a regular grid, and nanowire structures, in which much smaller metal structures form a random network. This report covers only metal meshes, …
- 中国のエネルギー産業分析：Analyzing China’s Energy IndustryThe People’s Republic of China is often referred to as the home of the Red Dragon which in oriental terms is considered to be auspicious and an indicator of prosperity and a storehouse of wealth. The PRC was not always aware of its self reliant resources till the time it moved ahead of the Russian dependence and extracted its own resources wherein it has produced energy from oil and progressed to …
- Diffuse Diabetic Macular Edema：治療薬のグローバル治験動向（2014年上半期）Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2014" provides data on the Diffuse Diabetic Macular Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diffuse Diabetic Macular Edema. It includes an o …
- ジオシンセティックスの世界市場2018-2022About Geosynthetics Geosynthetics are products made from polymeric materials and are applied as key components in a structure or system to achieve engineering purposes. Certain basic functions of geosynthetics are separation, reinforcement, filtration, drainage, containment, barrier, surface erosion control, and protection; geosynthetic products are expected to provide one or more of these functio …
- スマートネックレスの世界市場2019-2023About this market Increasing crime rates increases the demand for women safety devices to drive market growth. With the rising incidences of crime on women, it is necessary to have smart technology to combat constant threats to their ability to move around, to work, and lead a normal life. Technavio’s analysts have predicted that the smart necklace market will register a CAGR of close to 2% by 202 …
- 特発性肺線維症(Idiopathic Pulmonary Fibrosis)：治療薬開発パイプライン動向（2015年上半期版）Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Pulmonary Fibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with comparative analysis at various stages, t …
- 世界の原子力産業動向Nuclear power has been used for many years for generating electricity across the world. However, with the recent Fukushima nuclear disaster, the safety of nuclear power has been called into question, with many countries deciding to phase out nuclear power completely by 2020. With concerns rising about the use of conventional thermal energy sources, many are questioning whether one can truly phase …
- 世界のデジタル油田市場：分散制御システム、SCADA、スマートウェル、安全システム、ITサービスなどThe report has taken into consideration two scenarios and forecasted the market based on the assumptions made under each scenario. Scenario 1 is based on the current market environment which is characterized by participation from regions that have implemented the DOF solutions on a commercial basis. Scenario 2 presents a more optimistic projection for the market as it also takes into consideration …
- Rhinosinusitis：グローバル臨床試験レビューH2, 2013Rhinosinusitis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Rhinosinusitis Global Clinical Trials Review, H2, 2013" provides data on the Rhinosinusitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rhinosinusitis. It includes an overview of the trial numbers and their recruitment status as per …
- 増殖糖尿病網膜症(Proliferative Diabetic Retinopathy (PDR))：治療薬開発パイプライン動向（2015年上半期版）Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015’, provides an overview of the Proliferative Diabetic Retinopathy (PDR)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Proliferative Diabetic Retinopathy (PDR), complete wi …
- 世界のZigBee対応デバイス市場動向（2014-2018）TechNavio's analysts forecast the Global ZigBee Enabled Devices market to grow at a CAGR of 67.64 percent over the period 2013-2018. One of the key factors contributing to this market growth is extended battery life and power saving. The Global ZigBee Enabled Devices market has also been witnessing the increasing deployment of consumer-facing application devices with ZigBee technology. However, th …
- Canadian Natural Resources Limited：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Canadian Natural Resources Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Canadian Natural Resources Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The rep …
- スマート兵器の世界市場：ミサイル、弾薬、誘導弾、誘導ロケット、誘導火器The smart weapons market is projected to grow from USD 11.52 Billion in 2016 to USD 15.64 Billion by 2021, at a CAGR of 6.3% during the forecast period. Factors, such as armed conflicts, terror activities, cross-border disputes, and increasing military use of smart weapons are expected to fuel the growth of the smart weapons market during the forecast period. On the basis of product, the given mar …
